Five-year data demonstrate InterStim(TM) therapy offers sustained long-term efficacy
Medtronic announced that the InterStim(TM) system, which provides sacral neuromodulation therapy, offers sustained long-term efficacy and quality of life improvements for overactive bladder at five years. The study results were published in the Journal of Urology. July 17, 2017
